Cobicistat

Paul G. Auwaerter, M.D., Janessa M. Smith, PharmD, BCPS
Cobicistat is a topic covered in the Johns Hopkins HIV Guide.

To view the entire topic, please or .

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • HIV therapy, used as pharmacokinetic enhancement compound used with ATV, DRV (800 mg once daily only) or EVG

-- To view the remaining sections of this topic, please or --

INDICATIONS

FDA

  • HIV therapy, used as pharmacokinetic enhancement compound used with ATV, DRV (800 mg once daily only) or EVG

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: November 9, 2022